Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Fennelly

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
BMC Infectious Diseases|January 22, 2022
The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohortRebekah A Blakney, Emily E Ricotta, Dean Follmann, et al.
Nature Medicine|July 1, 2020
Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosisGrant Theron, Jason Limberis, Rouxjeane Venter, et al.
Plos Medicine|March 23, 2011
Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort studyEdward C Jones-López, Irene Ayakaka, Jonathan Levin, et al.
The Lancet. Respiratory Medicine|March 26, 2022
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventionsKeertan Dheda, Tahlia Perumal, Harry Moultrie, et al.
Plos One|March 11, 2014
Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort studyBruce J Kirenga, Jonathan Levin, Irene Ayakaka, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 26, 2017
Frequency of untreated hypogammaglobulinemia in bronchiectasisMelanie A Ruffner, Timothy R Aksamit, Byron Thomashow, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 12, 2019
The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research RegistryEdward Eden, Radmila Choate, Alan Barker, et al.
Chest|July 6, 2020
Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research RegistryAshwin Basavaraj, Radmila Choate, Doreen Addrizzo-Harris, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 27, 2020
Nutrition and Markers of Disease Severity in Patients With BronchiectasisKatherine A Despotes, Radmila Choate, Doreen Addrizzo-Harris, et al.
Respiratory Medicine|January 5, 2021
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) studyRadmila Choate, Timothy R Aksamit, David Mannino, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
BMC Infectious Diseases|January 22, 2022
The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohortRebekah A Blakney, Emily E Ricotta, Dean Follmann, et al.
Nature Medicine|July 1, 2020
Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosisGrant Theron, Jason Limberis, Rouxjeane Venter, et al.
Plos Medicine|March 23, 2011
Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort studyEdward C Jones-López, Irene Ayakaka, Jonathan Levin, et al.
The Lancet. Respiratory Medicine|March 26, 2022
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventionsKeertan Dheda, Tahlia Perumal, Harry Moultrie, et al.
Plos One|March 11, 2014
Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort studyBruce J Kirenga, Jonathan Levin, Irene Ayakaka, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 26, 2017
Frequency of untreated hypogammaglobulinemia in bronchiectasisMelanie A Ruffner, Timothy R Aksamit, Byron Thomashow, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 12, 2019
The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research RegistryEdward Eden, Radmila Choate, Alan Barker, et al.
Chest|July 6, 2020
Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research RegistryAshwin Basavaraj, Radmila Choate, Doreen Addrizzo-Harris, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 27, 2020
Nutrition and Markers of Disease Severity in Patients With BronchiectasisKatherine A Despotes, Radmila Choate, Doreen Addrizzo-Harris, et al.
Respiratory Medicine|January 5, 2021
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) studyRadmila Choate, Timothy R Aksamit, David Mannino, et al.
Pageof 3